<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03575546</url>
  </required_header>
  <id_info>
    <org_study_id>KP05A</org_study_id>
    <nct_id>NCT03575546</nct_id>
  </id_info>
  <brief_title>Clinical and Functional Outcome of the Gemini SL Fixed Bearing at Midterm Follow-up</brief_title>
  <official_title>Clinical and Functional Outcome of the Gemini SL Fixed Bearing at Midterm Follow-up</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Waldemar Link GmbH &amp; Co. KG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Waldemar Link GmbH &amp; Co. KG</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a retrospective, multicenter case series with a prospective follow-up to confirm the
      safety and performance of the Gemini SL Fixed Bearing knee prosthesis in midterm follow-up
      under routine conditions. Primary outcome of the study is the 5-year survival rate of the
      Gemini SL Fixed Bearing knee prosthesis with revision for any reason as the end point.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Sufficient data (e.g. biomechanical tests, biocompatibility, vigilance data and results of
      risk management, clinical data of comparable devices) are available for assessing the safety
      and performance of the Gemini SL knee prosthesis system. Unfortunately, no data are available
      for the Gemini SL Fixed Bearing knee prosthesis. As one part of the post market surveillance
      (PMS) system of the sponsor, the clinical outcome of the Gemini SL Fixed Bearing knee
      prosthesis in the midterm follow-up shall be evaluated. Therefore patients who received a
      Gemini Sl Fixed bearing knee prosthesis 3 years ago are invited to participate in follow-up
      examinations.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 24, 2018</start_date>
  <completion_date type="Anticipated">September 2023</completion_date>
  <primary_completion_date type="Anticipated">September 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Survival rate of the Gemini SL Fixed Bearing knee prosthesis with revision for any reason as the end point</measure>
    <time_frame>5 years</time_frame>
    <description>Revision for any reason is defined as removal, replacement or adding of any implant components, except subsequent implantation or replacement of the patella surface or the polyethylene plateau.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Survival rate of the Gemini SL Fixed Bearing knee prosthesis with revision for any reason as the end point</measure>
    <time_frame>3 years</time_frame>
    <description>Revision for any reason is defined as removal, replacement or adding of any implant components, except subsequent implantation or replacement of the patella surface or the polyethylene plateau.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of the functional and clinical outcome of the Gemini SL Fixed Bearing knee prosthesis measured by the Knee Society Score</measure>
    <time_frame>3 and 5 year</time_frame>
    <description>Evaluation of KSS Score (Validated Score)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complication rates</measure>
    <time_frame>3 and 5 years</time_frame>
    <description>Number and kind of complications</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subsequent surgical interventions</measure>
    <time_frame>3 and 5 years</time_frame>
    <description>Number and kind of subsequent surgical interventions</description>
  </secondary_outcome>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Total Knee Replacement</condition>
  <eligibility>
    <study_pop>
      <textblock>
        All patients received a Gemini SL Fixed Bearing knee prosthesis in the study sites 3 years
        ago are possible participants of the study. Hospital charts will be screened in order to
        identify these candidates. The patients will be followed up at 3-year interval.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Implantation of a Gemini SL Fixed Bearing knee prostheses 3 years ago

          -  Age between 18 and 75 years at the time of implantation

        Exclusion Criteria:

          -  Body Mass Index (BMI) &gt; 40 kg/m² at the time of implantation

          -  Comorbidities and known medical circumstances which would affect the clinical
             functional outcome after implantation of the knee prosthesis (e.g. neurological or
             musculoskeletal diseases) at the time of implantation

          -  Prisoner
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Prof. Dr. med. Wülker</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitätsklinikum Tübingen für Orthopädie</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Studycoordinator</last_name>
    <phone>+4940539950</phone>
    <email>studies@linkhh.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Klinik Oberammergau</name>
      <address>
        <city>Oberammergau</city>
        <zip>82487</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Arbogast, Dr. med.</last_name>
      <phone>+4988229140</phone>
      <email>martin.arbogast@wz-kliniken.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Tübingen für Orthopädie</name>
      <address>
        <city>Tübingen</city>
        <zip>72076</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Wülker, Prof.Dr.med.</last_name>
      <phone>+4970712986033</phone>
      <email>niko.wuelker@med.uni-tuebingen.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital central de la Cruz Roja</name>
      <address>
        <city>Madrid</city>
        <zip>28003</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Menéndez, Dr.</last_name>
      <phone>+34660959379</phone>
      <email>pbmenendez@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
    <country>Spain</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>June 15, 2018</study_first_submitted>
  <study_first_submitted_qc>June 28, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 2, 2018</study_first_posted>
  <last_update_submitted>October 1, 2019</last_update_submitted>
  <last_update_submitted_qc>October 1, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 2, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

